Chugai Pharmaceutical Co Ltd’s (CHGCF) Moving Averages Convergence Divergence (MACD) indicator is -0.44, suggesting Chugai Pharmaceutical Co Ltd is a Sell.

Chugai Pharmaceutical Co Ltd’s (CHGCF) 20-Day exponential moving average is 42.71, while Chugai Pharmaceutical Co Ltd’s (CHGCF) share price is $41.8, making it a Sell.

Chugai Pharmaceutical Co Ltd’s (CHGCF) 50-Day exponential moving average is 43.72, while Chugai Pharmaceutical Co Ltd’s (CHGCF) share price is $41.8, making it a Sell.

Chugai Pharmaceutical Co (CHGCF) Pivot Points

Dec 22, 2024, 10:36 PM

Classic

35.46

38.22

39.98

42.74

44.50

47.26

49.02

Fibonacci

38.22

39.95

41.02

42.74

44.47

45.54

47.26

Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Chugai Pharmaceutical Co (CHGCF) Moving Averages

Dec 22, 2024, 10:36 PM

MA5

42.61Sell

42.32Sell

MA10

42.46Sell

42.47Sell

MA20

42.45Sell

42.71Sell

MA50

44.34Sell

43.72Sell

MA100

45.55Sell

43.57Sell

MA200

40.36Buy

40.87Buy

Chugai Pharmaceutical Co Ltd’s (CHGCF) 10-Day exponential moving average is 42.47, while Chugai Pharmaceutical Co Ltd’s (CHGCF) share price is $41.8, making it a Sell.

Chugai Pharmaceutical Co Ltd’s (CHGCF) 100-Day exponential moving average is 43.57, while Chugai Pharmaceutical Co Ltd’s (CHGCF) share price is $41.8, making it a Sell.

Chugai Pharmaceutical Co Ltd’s (CHGCF) stock price is $41.8 and Chugai Pharmaceutical Co Ltd’s (CHGCF) 50-day simple moving average is 44.34, creating a Sell signal.

Chugai Pharmaceutical Co Ltd’s (CHGCF) stock price is $41.8 and Chugai Pharmaceutical Co Ltd’s (CHGCF) 100-day simple moving average is 45.55, creating a Sell signal.

Chugai Pharmaceutical Co Ltd’s (CHGCF) stock price is $41.8 and Chugai Pharmaceutical Co Ltd’s (CHGCF) 200-day simple moving average is 40.36, creating a Buy signal.

Chugai Pharmaceutical Co (CHGCF) Technical Indicators

Dec 22, 2024, 10:36 PM

RSI (14)

46.42

Neutral

STOCH (9,6)

26.51

Neutral

STOCHRSI (14)

25.66

Neutral

MACD (12,26)

-0.44

Sell

ADX (14)

26.48

Neutral

Williams %R

-80.93

Buy

CCI (14)

-55.93

Neutral

ATR (14)

4.47

Ultimate Oscillator

20.55

Sell

ROC

-9.99

Sell

Chugai Pharmaceutical Co Ltd’s (CHGCF) Relative Strength Index (RSI) is 46.42, creating a Neutral signal.

Chugai Pharmaceutical Co Ltd’s (CHGCF) Trend Strength Indicator (ADX) is 26.48, creating a Neutral signal.

Chugai Pharmaceutical Co Ltd’s (CHGCF) Commodity Channel Index (CCI) is -55.93, creating a Neutral signal.

Chugai Pharmaceutical Co Ltd’s (CHGCF) Price Rate of Change (ROC) is -9.99, creating a Sell signal.

Technical Analysis Screener >

Technical Analysis Screener.

Customize your technical analysis to fit your
unique trading strategy with a flexible screener

Try it Now!

FAQ

Is CHGCF a Buy, Hold, or Sell?

Based on CHGCF’s technical indicators, CHGCF is a Sell.

What is CHGCF’s RSI (14)?

CHGCF’s RSI (14) is 46.42, which suggests CHGCF is a Neutral.

What is CHGCF’s MACD?

CHGCF’s MACD is -0.44, which suggests CHGCF is a Sell.

What is CHGCF’s 5-day moving average?

CHGCF’s 5-day moving average is 42.61, which suggests CHGCF is a Sell.

What is CHGCF’s 20-day moving average?

CHGCF 20-day moving average is 42.45, which suggests CHGCF is a Sell.

What is CHGCF’s 50-day moving average?

CHGCF’s 50-day moving average is 44.34, which suggests CHGCF is a Sell.

What is CHGCF’s 200-day moving average?

CHGCF’s 200-day moving average is 40.36, which suggests CHGCF is a Buy.

What is CHGCF’s Williams % R (14)?

CHGCF’s Williams % R (14) is -80.93, which suggests CHGCF is a Buy.

What is CHGCF’s CCI (14)?

CHGCF’s CCI (14) is -55.93, which suggests CHGCF is a Neutral.

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing